Ligibel JA - Search Results

1

Body Mass Index, PAM50 Subtype, and Outcomes in Node-Positive Breast Cancer: CALGB 9741 (Alliance).

Ligibel JA, Cirrincione CT, Liu M, Citron M, Ingle JN, Gradishar W, Martino S, Sikov W, Michaelson R, Mardis E, Perou CM, Ellis M, Winer E, Hudis CA, Berry D, Barry WT. Ligibel JA, et al. J Natl Cancer Inst. 2015 Jun 25;107(9):djv179. doi: 10.1093/jnci/djv179. Print 2015 Sep. J Natl Cancer Inst. 2015. PMID: 26113580 Free PMC article. Clinical Trial.

2

The aromatase inhibitors as adjuvant therapy for hormone receptor-positive breast cancer.

Ligibel JA, Winer EP. Ligibel JA, et al. J Natl Compr Canc Netw. 2003 Apr;1(2):215-21. doi: 10.6004/jnccn.2003.0020. J Natl Compr Canc Netw. 2003. PMID: 19768880 Review.

3

Response.

Ligibel JA, Winer E, Hudis CA, Barry WT. Ligibel JA, et al. J Natl Cancer Inst. 2016 Jan;108(1). doi: 10.1093/jnci/djv334. J Natl Cancer Inst. 2016. PMID: 26719886 No abstract available.

4

Trastuzumab/chemotherapy combinations in metastatic breast cancer.

Ligibel JA, Winer EP. Ligibel JA, et al. Semin Oncol. 2002 Jun;29(3 Suppl 11):38-43. doi: 10.1053/sonc.2002.34054. Semin Oncol. 2002. PMID: 12138396 Review.

5

Clinical differences among the aromatase inhibitors.

Ligibel JA, Winer EP. Ligibel JA, et al. Clin Cancer Res. 2003 Jan;9(1 Pt 2):473S-9S. Clin Cancer Res. 2003. PMID: 12538503 Review.

6

Aromatase inhibitors as adjuvant therapy for postmenopausal women: a therapeutic advance but many unresolved questions.

Ligibel JA, Winer EP. Ligibel JA, et al. Breast Cancer Res. 2005;7(6):255-7. doi: 10.1186/bcr1347. Epub 2005 Nov 11. Breast Cancer Res. 2005. PMID: 16457700 Free PMC article. Review.

7

Aromatase inhibitors in the adjuvant treatment of postmenopausal women with early stage breast cancer.

Ligibel JA, Winer EP. Ligibel JA, et al. Womens Health (Lond). 2006 Jan;2(1):89-97. doi: 10.2217/17455057.2.1.89. Womens Health (Lond). 2006. PMID: 19803930 Free article.

8

Randomized trial of a physical activity intervention in women with metastatic breast cancer.

Ligibel JA, Giobbie-Hurder A, Shockro L, Campbell N, Partridge AH, Tolaney SM, Lin NU, Winer EP. Ligibel JA, et al. Cancer. 2016 Apr 15;122(8):1169-77. doi: 10.1002/cncr.29899. Epub 2016 Feb 12. Cancer. 2016. PMID: 26872302 Free article. Clinical Trial.

9

The impact of actual body weight-based chemotherapy dosing and body size on adverse events and outcome in older patients with breast cancer: Results from Cancer and Leukemia Group B (CALGB) trial 49907 (Alliance A151436).

Morrison VA, McCall L, Muss HB, Jatoi A, Cohen HJ, Cirrincione CT, Ligibel JA, Lafky JM, Hurria A. Morrison VA, et al. Among authors: ligibel ja. J Geriatr Oncol. 2018 May;9(3):228-234. doi: 10.1016/j.jgo.2017.11.007. Epub 2017 Dec 8. J Geriatr Oncol. 2018. PMID: 29233548 Free PMC article. Clinical Trial.

10

Race and hormone receptor-positive breast cancer outcomes in a randomized chemotherapy trial.

Sparano JA, Wang M, Zhao F, Stearns V, Martino S, Ligibel JA, Perez EA, Saphner T, Wolff AC, Sledge GW Jr, Wood WC, Davidson NE. Sparano JA, et al. Among authors: ligibel ja. J Natl Cancer Inst. 2012 Mar 7;104(5):406-14. doi: 10.1093/jnci/djr543. Epub 2012 Jan 16. J Natl Cancer Inst. 2012. PMID: 22250182 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

151 results

Search Page